AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2023

Nov 21, 2023

30071_dirs_2023-11-20_b051107e-ec48-4a24-bba1-3127fabe481c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2023-11-16

Reporting Person: FARRELL PETER C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-16	ResMed Common Stock	A	1768	—	Acquired	180939	Direct

Footnotes

F1: Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2024, or the annual shareholders meeting in the year following the grant date.